Business Wire

INMARSAT

9.3.2023 08:01:34 CET | Business Wire | Press release

Share
Inmarsat: Greener Flights Coming to Italy Soon as ITA Airways to Join Iris Air Traffic Modernisation Programme

Digitally-connected flights to and from Italy will be available from this summer, as ITA Airways rolls out the European Space Agency (ESA) and Inmarsat’s ground-breaking Iris data link technology to the cockpits of its full aircraft fleet, contributing to airspace modernisation in Europe.

ITA Airways will be the first full service carrier in Europe to join Iris. The programme enables aircraft to fly more fuel-efficient routes by providing digital satellite communications to complement VHF data link, which is nearing a capacity crunch in congested airspace. Without fast and reliable data links between aircraft and the ground, air traffic managers cannot unlock the 8-10% reduction in CO2 emissions identified by EUROCONTROL from improved Air Traffic Management (ATM). Iris will allow ATM players to better anticipate and collaborate to maximise airspace use, reducing the impact of disruptions for passengers while reducing emissions.

The Italian national carrier will equip its full fleet of new Airbus A320neo and A330neo aircraft deliveries with Inmarsat’s SwiftBroadband-Safety (SB-S), the award-winning platform flying on more than 230 aircraft globally, which powers Iris. Its aircraft will also play a significant role in Iris demonstration flights, which will take place across European airspace supported by 14 Air Navigation Service Providers (ANSPs) during 2023.

This news comes as five more airlines have now equipped aircraft with Inmarsat SB-S, after Airbus’ Light Cockpit Satcom (LCS) terminal became available to order in December 2022. Current SB-S users include Virgin Atlantic, Jet2, and Transavia Airlines, in addition to ITA Airways and easyJet.

Across the seven European airlines, 72 aircraft deliveries with Airbus LCS installed are anticipated during 2023-2024. Iris-capable Inmarsat terminals across many more of Europe’s commercial airlines will further support the Single European Sky ATM Research (SESAR) masterplan.

Alessio Leone, Head of Camo Operations, at ITA Airways said “ITA Airways was born to guarantee Italy quality connectivity with a strong focus on the environmental impact through an important investment made in a homogeneous and technologically advanced fleet, which in 2026 will be made up of 80% of new generation aircrafts becoming the greenest fleet in Europe. We are proud to join the Iris programme, which is fully in line with our growth strategy as it reflects two of the core pillars of ITA Airways: sustainability and innovation. ITA Airways is the first full service carrier in Europe with a new fleet fully equipped with this cutting-edge technology by Inmarsat Aviation, delivering operational and environmental benefits.”

Joel Klooster, Inmarsat Aviation’s Senior Vice President of Aircraft Operations and Safety, said “We are delighted to welcome ITA Airways as the second airline to join Iris, coming only months after easyJet was announced as the first airline. This shows the impressive momentum that continues to build around the programme as it heads towards commercial service introduction in Europe this year, followed by a full global rollout. Iris will mark a transformational step-change in air traffic management, delivering operational and environment benefits for airlines and the aviation industry as a whole, while also enhancing the flight experience for passengers.”

Javier Benedicto, Acting Director of Telecommunications and Integrated Applications at ESA, said: “We are proud to support the space-enabled digitalisation of Europe’s skies, which will help to make aviation greener. ESA developed the Iris system in partnership with Inmarsat and we welcome ITA Airways as the first full service carrier and the second airline to sign up to use it. Investing in space improves life on Earth.”

ENDS

NOTES TO EDITORS:

ITA follows easyJet, which became the first airline to join the programme last June.

ABOUT ITA AIRWAYS

ITA Airways is a company totally owned by the Italian Ministry of Economy and Finance for the exercise of business in the air transport sector. ITA Airways aims at creating an efficient and innovative air carrier that will become a reference point in providing Italy with quality connectivity both in terms of international destinations, thus boosting tourism and foreign trade, and within the Country, also taking advantage of the train-air integrated mobility. ITA Airways will place the best customer service at the center of its strategy (through a strong digitization of processes that ensure a best-in-class experience and personalized services), combined with sustainability, in its environmental (new green and technologically advanced aircraft, use of sustainable fuels), social (equality and inclusion for a gender-neutral company) and governance (integration of sustainability into internal strategies and processes) aspects. ITA Airways is a member of SkyTeam alliance as of October 2021.

ABOUT INMARSAT

Inmarsat delivers world leading, innovative, advanced and exceptionally reliable global, mobile communications across the world – in the air, at sea and on land - that are enabling a new generation of commercial, government and mission-critical services. Inmarsat is powering the digitalisation of the maritime industry, making operations more efficient and safer than ever before. It is driving a new era of inflight passenger services for aviation, while ensuring that aircraft can fly with maximum efficiency and safety. Furthermore, Inmarsat is enabling the rapid expansion of the Internet of Things (IoT) and enabling the next wave of world-changing technologies that will underpin the connected society and help build a sustainable future. And now Inmarsat is developing the first-of-its-kind, multi-dimensional communications network of the future, ORCHESTRA.

In November 2021, Inmarsat and Viasat announced the planned combination of the two companies, to create a new leader in global communications.

For further information, follow us: Twitter | LinkedIn | Facebook | YouTube | Instagram.

ABOUT IRIS

Iris benefits airlines and ANSPs by bringing the bandwidth and reliability to allow digital exchanges between the aircraft and ground systems. System-to-system digital communication enables flights to be managed more efficiently through trajectory-based operations. These 4 Dimensional Trajectory-Based Operations (4D TBO) improve the management of airspace capacity, unlocking operational efficiency for airlines by avoiding holding patterns, accessing improved routes and optimum altitudes, and using continuous climb and descent pathways. The additional datalink capacity provided by SB-S will also power a host of onboard digital applications, such as AI flight profile optimisers and real-time weather applications.

European Union Aviation Safety Agency (EASA) certification of ESSP as the Communication Service Provider for the Iris data link service is nearing completion, and will mark the first air navigation service provider to own a pan-European certificate that allows cross-border delivery of air traffic management services.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230308005515/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye